A Prospective Trial on the Effect of Body Mass Index and Sex on Plasma Octreotide Levels in Patients Undergoing Long-Term Octreotide LAR Therapy

Pancreas - United States
doi 10.1097/mpa.0b013e3181db01a8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Teste Agudo Com Octreotide Subcutâneo Como Preditor De Resposta Ao Tratamento Com Octreotide LAR®

Arquivos Brasileiros de Endocrinologia & Metabologia
2005English

Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors

Oncologist
Cancer ResearchMedicineOncology
2016English

Letter: Can Transient Elastography and Body Mass Index Predict Fibrosis Regression in HBV Patients on Long-Term Nucleoside Therapy?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Resistance to Octreotide LAR in Acromegalic Patients With High SSTR2 Expression: Analysis of AIP Expression

Arquivos Brasileiros de Endocrinologia & Metabologia
2012English

Effect of Body Mass Index on Morbidity and Mortality in Patients Undergoing Coronary Artery Bypass Grafting

The Egyptian Cardiothoracic Surgeon
2019English

Effect of Octreotide on Colonic Motility in Pediatric Patients With Chronic Recalcitrant Constipation

Journal of Pediatric Gastroenterology and Nutrition
Child HealthPediatricsPerinatologyGastroenterology
2015English

A Comparison Between Octreotide-Lar and Lanreotide-Sr in the Chronic Treatment of Acromegaly

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Medical Treatment of Benign Insulinoma Using Octreotide LAR: A Case Report

Endocrine Journal
EndocrinologyMetabolismDiabetes
2007English

Postoperative Chylothorax: Is Octreotide a Valid Therapy?

Journal of Case Reports and Studies
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy